Gut indigenous microbiota and epigenetics

This review introduces and discusses data regarding fundamental and applied investigations in mammalian epigenomics and gut microbiota received over the last 10 years. Analysis of these data enabled the author first to come to the conclusion that the multiple low molecular weight substances of indig...

Full description

Bibliographic Details
Main Author: Boris Arkadievich Shenderov
Format: Article
Language:English
Published: Taylor & Francis Group 2012-03-01
Series:Microbial Ecology in Health and Disease
Subjects:
Online Access:http://www.microbecolhealthdis.net/index.php/mehd/article/view/17195/21264
id doaj-1c8925eff4ca49069fe0c013991269cc
record_format Article
spelling doaj-1c8925eff4ca49069fe0c013991269cc2020-11-24T22:00:31ZengTaylor & Francis GroupMicrobial Ecology in Health and Disease0891-060X1651-22352012-03-012301610.3402/mehd.v23i0.17195Gut indigenous microbiota and epigeneticsBoris Arkadievich ShenderovThis review introduces and discusses data regarding fundamental and applied investigations in mammalian epigenomics and gut microbiota received over the last 10 years. Analysis of these data enabled the author first to come to the conclusion that the multiple low molecular weight substances of indigenous gut microbiota origin should be considered one of the main endogenous factors actively participating in epigenomic mechanisms that responsible for the mammalian genome reprogramming and post-translated modifications. Gut microecological imbalance coursed by various biogenic and abiogenic agents and factors can produce the different epigenetic abnormalities and the onset and progression of metabolic diseases associated. The author substantiates the necessity to create an international project ‘Human Gut Microbiota and Epigenomics’ that facilitates interdisciplinary collaborations among scientists and clinicians engaged in host microbial ecology, nutrition, metagenomics, epigenomics and metabolomics investigations as well as in diseases prevention and treatment. Some priority scientific and applied directions in the current omic technologies coupled with gnotobiological approaches are suggested that can open a new era in characterizing the role of the symbiotic microbiota small metabolic and signal molecules in the host epigenomics. Although discussed subject is only at an early stage its validation can open novel approaches in drug discovery studies.http://www.microbecolhealthdis.net/index.php/mehd/article/view/17195/21264gut microfloramicrobial small moleculesmammalian epigenomics
collection DOAJ
language English
format Article
sources DOAJ
author Boris Arkadievich Shenderov
spellingShingle Boris Arkadievich Shenderov
Gut indigenous microbiota and epigenetics
Microbial Ecology in Health and Disease
gut microflora
microbial small molecules
mammalian epigenomics
author_facet Boris Arkadievich Shenderov
author_sort Boris Arkadievich Shenderov
title Gut indigenous microbiota and epigenetics
title_short Gut indigenous microbiota and epigenetics
title_full Gut indigenous microbiota and epigenetics
title_fullStr Gut indigenous microbiota and epigenetics
title_full_unstemmed Gut indigenous microbiota and epigenetics
title_sort gut indigenous microbiota and epigenetics
publisher Taylor & Francis Group
series Microbial Ecology in Health and Disease
issn 0891-060X
1651-2235
publishDate 2012-03-01
description This review introduces and discusses data regarding fundamental and applied investigations in mammalian epigenomics and gut microbiota received over the last 10 years. Analysis of these data enabled the author first to come to the conclusion that the multiple low molecular weight substances of indigenous gut microbiota origin should be considered one of the main endogenous factors actively participating in epigenomic mechanisms that responsible for the mammalian genome reprogramming and post-translated modifications. Gut microecological imbalance coursed by various biogenic and abiogenic agents and factors can produce the different epigenetic abnormalities and the onset and progression of metabolic diseases associated. The author substantiates the necessity to create an international project ‘Human Gut Microbiota and Epigenomics’ that facilitates interdisciplinary collaborations among scientists and clinicians engaged in host microbial ecology, nutrition, metagenomics, epigenomics and metabolomics investigations as well as in diseases prevention and treatment. Some priority scientific and applied directions in the current omic technologies coupled with gnotobiological approaches are suggested that can open a new era in characterizing the role of the symbiotic microbiota small metabolic and signal molecules in the host epigenomics. Although discussed subject is only at an early stage its validation can open novel approaches in drug discovery studies.
topic gut microflora
microbial small molecules
mammalian epigenomics
url http://www.microbecolhealthdis.net/index.php/mehd/article/view/17195/21264
work_keys_str_mv AT borisarkadievichshenderov gutindigenousmicrobiotaandepigenetics
_version_ 1725844086843244544